超声引导微创尸检评估COVID-19肺及全身受累
巴西采用超声引导微创尸检对10例COVID-19患者进行多器官组织取样,组织学与RT-PCR检测SARS-CoV-2 RNA。所有患者均见渗出性/增生性弥漫性肺泡损伤,8例肺泡小动脉纤维蛋白血栓,全部肺泡巨核细胞高密度。结论认为MIA-US安全有效,COVID-19为系统性疾病,肺上皮与血管损伤均应纳入治疗策略。
要点
- 所有10例患者均显示渗出性/增生性弥漫性肺泡损伤。
- 8例肺泡小动脉见纤维蛋白血栓,全部患者肺泡巨核细胞高密度。
- 小血栓亦见于肾小球、脾、心、真皮、睾丸和肝窦,但频率较低。
核心结论
- COVID-19是系统性疾病,肺部主要事件由严重上皮损伤和微血栓性血管现象所致。
- 肺上皮与血管损伤均应纳入治疗策略。
- MIA-US是研究重症COVID-19安全有效的方法。
研究设计与样本
- 采用超声引导微创尸检(MIA-US)对10例初始尸检病例进行多器官组织取样。
- 取样器官包括肺、肝、心、肾、脾、脑、皮肤、骨骼肌和睾丸,行组织学检查及RT-PCR检测SARS-CoV-2 RNA。
主要发现
- 所有患者均显示渗出性/增生性弥漫性肺泡损伤。
- 呼吸道上皮(包括气道和肺泡细胞)见强烈多形性细胞病变效应。
- 8例患者肺泡小动脉存在纤维蛋白血栓,全部患者肺泡巨核细胞密度高。
- 肾小球、脾、心、真皮、睾丸和肝窦中小血栓较少见。
- 主要全身发现与合并症、年龄和脓毒症相关,另见可能的病毒感染所致组织损伤如肌炎、皮炎、心肌炎和睾丸炎。
关键数值与推荐
- 肺泡小动脉纤维蛋白血栓见于8例患者。
- 全部患者肺泡巨核细胞密度高。
- 所有患者均见渗出性/增生性弥漫性肺泡损伤。
临床怎么用
- 对重症COVID-19可采用MIA-US进行安全有效的尸检研究。
- 治疗上应同时针对肺上皮损伤和微血栓性血管现象。
- 尸检有助于确认疾病、确定相关合并症并研究病理生理。
局限性
- 仅报告10例初始尸检结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Brazil ranks high in the number of coronavirus disease 19 (COVID-19) cases and the COVID-19 mortality rate. In this context, autopsies are important to confirm the disease, determine associated conditions, and study the pathophysiology of this novel disease. The aim of this study was to assess the systemic involvement of COVID-19. In order to follow biosafety recommendations, we used ultrasound-guided minimally invasive autopsy (MIA-US), and we present the results of 10 initial autopsies. METHODS AND RESULTS: We used MIA-US for tissue sampling of the lungs, liver, heart, kidneys, spleen, brain, skin, skeletal muscle and testis for histology, and reverse transcription polymerase chain reaction to detect severe acute respiratory syndrome coronavirus 2 RNA. All patients showed exudative/proliferative diffuse alveolar damage. There were intense pleomorphic cytopathic effects on the respiratory epithelium, including airway and alveolar cells. Fibrinous thrombi in alveolar arterioles were present in eight patients, and all patients showed a high density of alveolar megakaryocytes. Small thrombi were less frequently observed in the glomeruli, spleen, heart, dermis, testis, and liver sinusoids. The main systemic findings were associated with comorbidities, age, and sepsis, in addition to possible tissue damage due to the viral infection, such as myositis, dermatitis, myocarditis, and orchitis. CONCLUSIONS: MIA-US is safe and effective for the study of severe COVID-19. Our findings show that COVID-19 is a systemic disease causing major events in the lungs and with involvement of various organs and tissues. Pulmonary changes result from severe epithelial injury and microthrombotic vascular phenomena. These findings indicate that both epithelial and vascular injury should be addressed in therapeutic approaches.
引用
- Duarte-Neto AN, Monteiro RAA, da Silva LFF, et al. Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy. Histopathology. 2020. PMID: 32443177. doi:10.1111/his.14160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。